IDYA: IDEAYA Biosciences, Inc. Common Stock Company Profile & Statistics

IDEAYA Biosciences, Inc. Common Stock Profile

About

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.

Info & Links

CEO

Yujiro Hata

Headquarters

5000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

131

IDEAYA Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

2.92B

Enterprise Value

2.62B

Enterprise Value/EBITDA(ttm)

-11.62

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.71

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

14.34%

Return on Equity(ttm)

-15.55%

Return on Invested Capital(ttm)

-16.51%

Return on Assets(ttm)

-14.44%

Income Statement

Revenue(ttm)

207.83M

Revenue Per Share(ttm)

2.37

Gross Profit(ttm)

207.83M

EBITDA(ttm)³

-225.21M

Net Income Available to Common(ttm)

-160.74M

Diluted EPS(ttm)

-1.86

Share Statistics

Beta (5Y Monthly)

0.04

52-Week Change

30.00%

S&P 500 52-Week Change

15.47%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

87.67M

Dividend Yield

0.00%

Float⁴

85.47M

% Held by Insiders

2.50%

% Held by Institutions

98.29%

Balance Sheet

Total Cash(mrq)

786.89M

Total Cash Per Share(mrq)

8.98

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.44%

Quick Ratio(mrq)

12.44%

Book Value Per Share(mrq)

12.46

Cash Flow

Operating Cash Flow Per Share(ytd)

0.22

Free Cash Flow(ytd)

17.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IDYA

IDEAYA Biosciences, Inc. Common Stock